CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-22 | De Backer Marianne Chief Executive Officer | Grant or award 10b5-1 | +285,000 | 1,054,505 | ||
| 2026-02-22 | De Backer Marianne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +570,000 | 570,000 | ||
| 2026-02-13 | Sabatini Brent SVP, Chief Accounting Officer | Sale 10b5-1 | −1,530 | $7.79 | $12K | 47,872 |
| 2026-02-02 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $7.71 | $170K | 1,144,391 |
| 2026-01-02 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $5.93 | $130K | 1,166,391 |
| 2025-12-01 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −191,854 | $5.98 | $1.1M | 13,728,924 |
| 2025-12-01 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $6.00 | $132K | 1,188,391 |
| 2025-11-28 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −61,493 | $6.44 | $396K | 13,920,778 |
| 2025-11-26 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −127,938 | $6.39 | $818K | 13,982,271 |
| 2025-11-25 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −235,971 | $6.38 | $1.5M | 14,110,209 |
| 2025-11-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −227,803 | $6.15 | $1.4M | 14,346,180 |
| 2025-11-17 | O'Byrne Jason EVP & Chief Financial Officer | Sale 10b5-1 | −6,799 | $5.56 | $38K | 110,701 |
| 2025-11-05 | de Verneuil Vanina EVP, General Counsel, Corp Sec | Sale 10b5-1 | −2,385 | $5.16 | $12K | 78,210 |
| 2025-11-03 | de Verneuil Vanina EVP and General Counsel | Sale 10b5-1 | −1,365 | $5.86 | $8K | 80,595 |
| 2025-11-03 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $5.64 | $124K | 1,210,391 |
| 2025-10-29 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −100 | $6.49 | $649 | 14,573,983 |
| 2025-10-28 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −24,453 | $6.50 | $159K | 14,574,083 |
| 2025-10-27 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −66,403 | $6.05 | $402K | 14,598,536 |
| 2025-10-24 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −46,696 | $5.96 | $278K | 14,664,939 |
| 2025-10-23 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −154,383 | $5.99 | $925K | 14,711,635 |
Page 4 of 54 · 1,063 trades